Transdermal scopolamine use for post-rhytidectomy sialocele.
BACKGROUND
Post-rhytidectomy sialocele is a rare complication. The usual treatment uses prolonged drainage. The use of antisialogogues has been described previously, but has potential side effects. Transdermal scopolamine SCOPODERM TTS is indicated for the prevention of motion sickness and also has antisialogugue action.


METHODS
An interventional case report is presented.


RESULTS
The application of transdermal scopolamine SCOPODERM TTS resulted in resolution of a post-rhytidectomy sialocele within 6 days.


CONCLUSIONS
Transdermal scopolamine delivery should be considered as an option for the treatment of post-rhytidectomy parotid fistulas.
Lapid
Oren
O
Department of Plastic and Reconstructive Surgery, Soroka University Medical Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer-Sheba, Israel. olapid@bgumail.bgu.ac.il
Kreiger
Yuval
Y
Sagi
Amiram
A
D000279:Administration, Cutaneous; D005260:Female; D005402:Fistula / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D008875:Middle Aged; D018727:Muscarinic Antagonists / Q000008:administration & dosage*; D010305:Parotid Diseases / Q000209:etiology / Q000517:prevention & control; D011183:Postoperative Complications / Q000517:prevention & control; D015361:Rhytidoplasty / Q000009:adverse effects* / Q000534:rehabilitation; D012472:Salivation / Q000187:drug effects*; D012601:Scopolamine / Q000008:administration & dosage*; D012798:Sialorrhea / Q000188:drug therapy* / Q000209:etiology; D013997:Time Factors; D016896:Treatment Outcome
D018727:Muscarinic Antagonists; D012601:Scopolamine